💡 Cognition Therapeutics (CGTX) — The $80M Alzheimer’s Biotech Poised for a $1B Breakout in 2025
Cognition Therapeutics (CGTX) is developing a breakthrough Alzheimer’s therapy showing up to 95% slowdown in early studies. Could this $80M biotech be the next billion-dollar…